Location: Home
  • search
  • go
  • Relate News
  • 3/9/2022Snapshot of MNC Pharma's China Performance in 2021 (Updated)
  • 3/9/2022Lonza Expands API Development and Manufacturing Laboratories in Nansha
  • 3/9/2022Hanmi to Launch High Blood Pressure Drug Amosartan in China
  • 3/9/2022China Meheco Inks Deal to Market Pfizer's Covid Pill Paxlovid in China
  • 3/7/2022Altamira and Nuance Enter Licensing and Distribution Deal for Bentrio ...
  • 3/7/2022Hutchmed Gets $15M from AstraZeneca as Part of Orpathys Drug Program i...
  • 3/7/2022J&J Reportedly in Talks for Biotech Deals in China
  • 3/7/2022NHSA Releases Its 2021 Healthcare Security Sector Development Statisti...
  • 3/7/2022NHC Establishes the Pharmacy Management and Drug Therapy Committee
  • 3/7/2022Central Government Report Emphasizes on Nine Healthcare Reform Measure...
  • 3/4/2022Drug R&D and Product Registration News Digest March 2022 (1)
  • 3/4/2022Recent Executive Moves
  • 3/3/2022China Conditionally Approves First Recombinant Protein COVID-19 Vaccin...
  • 3/3/2022WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at ...
  • 3/3/2022Aquestive and Haisco Enter Licensing and Supply Deal for Riluzole Oral...
  • 3/3/2022Eutilex Signs MOU with OBiO for Developing Cell Therapies in China
  • 3/3/2022Lesson from China's National Negotiation of Drug Prices in 2021 (NLR)
  • 3/3/2022Domestic Chinese Checkpoint Inhibitors: A Big Threat to Western Pharm...
  • 3/2/2022FDA OKs J&J and Legend's BCMA CAR-T, Setting Stage for Showdown with B...
  • 3/2/2022Adagene and Sanofi Enter SAFEbody Multi-Target Collaboration for Nove...
  • 3/2/2022CDE Publicizes the List of Reference Formulations for GQCE Studies (56...
  • 3/2/2022Gene Therapy Startup Grit Science Raises CNY Hundreds of Millions
  • 3/2/2022Tasly Reportedly Eyeing to Terminate License Pact with Sutro Biopharma
  • 3/2/2022The New Chinese Physicians Law Contains Provisions on Clinical Guideli...
  • 3/1/2022Financial-related Company News Digest
  • 3/1/2022Drug R&D and Product Registration News Digest February 2022 (3)
  • 3/1/2022Digestome Therapeutics Licenses Schizophrenia Drug DGX-001 for Greater...
  • 3/1/2022Heidelberg Pharma and Huadong Announce Strategic Partnership, Includin...
  • 2/28/2022Most MNCs and Domestics Face Serious Headwinds, But Some Managed to Ex...
  • 2/26/2022IQVIA: Chinese Hospital Drug Market Rose 2.2% in MAT Q4/2021
  • Page:170/797 Total number of articles:23898: [First][<<] [168] [169] [170] [171] [172] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group